Use of Virtual Reality Technologies in Management of Anxiety and Discomfort During Endoscopy Procedure
CARVENDO
2 other identifiers
interventional
50
0 countries
N/A
Brief Summary
Digestive endoscopies are performed either for diagnostic purposes (e.g. suspicion of cancer or monitoring of chronic diseases) or for therapeutic purposes (treatment of digestive haemorrhage, removal of polyps, etc.). Some endoscopies are performed under local anaesthetic, which can cause considerable anxiety in anticipation of the procedure and considerable discomfort during the procedure. Other endoscopies are performed under general anaesthetic for more extensive procedures on outpatients or inpatients. Anxiety prior to anaesthesia is likely to increase the perception of pain, increase the need for anaesthetic products and thus increase the time to complete awakening. Complementary techniques such as hypnotherapy can be used before the operation, with proven effectiveness. But these techniques require dedicated and specifically trained staff, as well as additional time. Virtual reality technologies, and in particular virtual reality headsets, allow instant immersion in a relaxing world. Therapeutic virtual reality headsets (TRVH) have been shown to be effective in reducing pre-operative anxiety and pain perception. Our hypothesis is that the use of a CRVT could reduce the consumption of anaesthetic products, reduce anxiety, improve overall satisfaction and reduce the length of outpatient hospitalisation during digestive endoscopy procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2025
CompletedFirst Posted
Study publicly available on registry
May 31, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
May 31, 2025
May 1, 2025
1.5 years
April 25, 2025
May 30, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
total propofol consumption
To compare total propofol consumption between patients who received CRVT immersion and control patients.
at day 1
Secondary Outcomes (4)
Time of awakening
at day 1
patient satisfaction
at day 1
post-endoscopy anxiety assessement
at baseline and at day 1
Duration of hospitalization
at day 1
Study Arms (2)
With virtual reality technologies
EXPERIMENTALPatients with virtual reality technologies during endoscopy procedure
Without virtual reality technologies
NO INTERVENTIONRoutine procedure of endoscopy
Interventions
Contribution of the use of a Therapeutic Virtual Reality Headset in the management of anxiety and discomfort in digestive endoscopy
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years (adult patients)
- Affiliated with a French social security system
- No legal protection measures (e.g., guardianship, curatorship)
- Scheduled for outpatient digestive endoscopy (upper or lower) under general anesthesia, level 1 (excluding biliary or interventional procedures)
- Medical indication for the endoscopic procedure established by a clinician
You may not qualify if:
- History of epilepsy
- Claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas BAZIN, MD, PhD
CHU Ambroise Paré, APHP, France
Central Study Contacts
Paul Dessaint, MD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2025
First Posted
May 31, 2025
Study Start
July 1, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
May 31, 2025
Record last verified: 2025-05